PT1370668E - Vacinas de vector baseadas em leporipox - Google Patents
Vacinas de vector baseadas em leporipoxInfo
- Publication number
- PT1370668E PT1370668E PT02732485T PT02732485T PT1370668E PT 1370668 E PT1370668 E PT 1370668E PT 02732485 T PT02732485 T PT 02732485T PT 02732485 T PT02732485 T PT 02732485T PT 1370668 E PT1370668 E PT 1370668E
- Authority
- PT
- Portugal
- Prior art keywords
- virus
- lepori
- exogenous dna
- host
- recombinant leporipox
- Prior art date
Links
- 229940126580 vector vaccine Drugs 0.000 title abstract 2
- 241000700563 Leporipoxvirus Species 0.000 abstract 4
- 108091029865 Exogenous DNA Proteins 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 230000009851 immunogenic response Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01200869 | 2001-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1370668E true PT1370668E (pt) | 2006-06-30 |
Family
ID=8179978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02732485T PT1370668E (pt) | 2001-03-08 | 2002-03-07 | Vacinas de vector baseadas em leporipox |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6942864B2 (pt) |
| EP (1) | EP1370668B1 (pt) |
| JP (1) | JP4037273B2 (pt) |
| CN (1) | CN1258596C (pt) |
| AT (1) | ATE318321T1 (pt) |
| AU (1) | AU2002304856B2 (pt) |
| BR (1) | BR0207761A (pt) |
| CA (1) | CA2439872C (pt) |
| DE (1) | DE60209345T2 (pt) |
| DK (1) | DK1370668T3 (pt) |
| ES (1) | ES2258628T3 (pt) |
| MX (1) | MXPA03007862A (pt) |
| NO (1) | NO331305B1 (pt) |
| NZ (1) | NZ527940A (pt) |
| PT (1) | PT1370668E (pt) |
| WO (1) | WO2002072852A2 (pt) |
| ZA (1) | ZA200306607B (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20090014364A (ko) * | 2006-06-01 | 2009-02-10 | 로바츠 리서치 인스티튜트 | 암 치료용 점액종 바이러스 변이종 |
| KR100831536B1 (ko) * | 2007-01-19 | 2008-05-22 | 리엔 창 일렉트로닉 엔터프라이즈 컴퍼니 리미티드 | 풀 브릿지 드라이버 |
| KR100831537B1 (ko) * | 2007-01-19 | 2008-05-22 | 리엔 창 일렉트로닉 엔터프라이즈 컴퍼니 리미티드 | 하프 브릿지 드라이버 |
| FR2925067B1 (fr) * | 2007-12-18 | 2010-01-15 | Agronomique Inst Nat Rech | Vecteurs vaccinaux derives de leporipoxvirus |
| US20230151387A1 (en) * | 2020-04-02 | 2023-05-18 | Arizona Board Of Regents On Behalf Of Arizona State University | Covid-19 vaccine based on the myxoma virus platform |
| CN111904981A (zh) * | 2020-09-07 | 2020-11-10 | 威世药业（如皋）有限公司 | 一种痘苗病毒致炎兔皮生产方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
| US5505941A (en) * | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| US5174993A (en) * | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
| DE10399031I1 (de) * | 1987-08-28 | 2004-01-29 | Health Research Inc | Rekombinante Viren. |
| WO1993001284A1 (en) | 1991-07-09 | 1993-01-21 | Cornell Research Foundation, Inc. | Recombinant viral vaccine |
| TW377373B (en) | 1993-09-22 | 1999-12-21 | Wyeth Corp | Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease |
| US6001349A (en) * | 1995-02-22 | 1999-12-14 | Therion Biologics Corporation | Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof |
| FR2736358B1 (fr) | 1995-07-05 | 1997-09-26 | Agronomique Inst Nat Rech | Virus myxomateux recombinant |
| AU4266597A (en) * | 1996-09-11 | 1998-04-14 | General Hospital Corporation, The | Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| US6127172A (en) | 1998-05-29 | 2000-10-03 | University Of Florida | Materials and methods for delivery and expression of heterologous DNA in vertebrate cells |
| ES2153284B1 (es) * | 1998-06-10 | 2001-09-01 | Fundacion Para El Estudio Y De | Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos. |
| US6294176B1 (en) * | 1998-07-10 | 2001-09-25 | Schering-Plough Veterinary Corp. | Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species |
-
2002
- 2002-03-07 JP JP2002571903A patent/JP4037273B2/ja not_active Expired - Fee Related
- 2002-03-07 ES ES02732485T patent/ES2258628T3/es not_active Expired - Lifetime
- 2002-03-07 BR BR0207761-2A patent/BR0207761A/pt not_active IP Right Cessation
- 2002-03-07 CA CA002439872A patent/CA2439872C/en not_active Expired - Fee Related
- 2002-03-07 DK DK02732485T patent/DK1370668T3/da active
- 2002-03-07 NZ NZ527940A patent/NZ527940A/en not_active IP Right Cessation
- 2002-03-07 MX MXPA03007862A patent/MXPA03007862A/es active IP Right Grant
- 2002-03-07 CN CN02806102.0A patent/CN1258596C/zh not_active Expired - Fee Related
- 2002-03-07 US US10/471,300 patent/US6942864B2/en not_active Expired - Fee Related
- 2002-03-07 DE DE60209345T patent/DE60209345T2/de not_active Expired - Lifetime
- 2002-03-07 EP EP02732485A patent/EP1370668B1/en not_active Expired - Lifetime
- 2002-03-07 WO PCT/EP2002/002858 patent/WO2002072852A2/en active IP Right Grant
- 2002-03-07 PT PT02732485T patent/PT1370668E/pt unknown
- 2002-03-07 AU AU2002304856A patent/AU2002304856B2/en not_active Ceased
- 2002-03-07 AT AT02732485T patent/ATE318321T1/de not_active IP Right Cessation
-
2003
- 2003-08-25 ZA ZA2003/06607A patent/ZA200306607B/en unknown
- 2003-09-04 NO NO20033912A patent/NO331305B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2258628T3 (es) | 2006-09-01 |
| CA2439872A1 (en) | 2002-09-19 |
| BR0207761A (pt) | 2006-01-31 |
| NO331305B1 (no) | 2011-11-21 |
| WO2002072852A3 (en) | 2002-12-27 |
| ZA200306607B (en) | 2005-02-23 |
| CN1258596C (zh) | 2006-06-07 |
| DE60209345T2 (de) | 2006-08-03 |
| MXPA03007862A (es) | 2004-05-24 |
| US6942864B2 (en) | 2005-09-13 |
| NO20033912D0 (no) | 2003-09-04 |
| DK1370668T3 (da) | 2006-06-06 |
| EP1370668B1 (en) | 2006-02-22 |
| DE60209345D1 (de) | 2006-04-27 |
| ATE318321T1 (de) | 2006-03-15 |
| JP4037273B2 (ja) | 2008-01-23 |
| NZ527940A (en) | 2005-01-28 |
| NO20033912L (no) | 2003-10-22 |
| AU2002304856B2 (en) | 2006-08-24 |
| JP2004528833A (ja) | 2004-09-24 |
| CA2439872C (en) | 2009-12-15 |
| CN1527883A (zh) | 2004-09-08 |
| US20040137599A1 (en) | 2004-07-15 |
| EP1370668A2 (en) | 2003-12-17 |
| WO2002072852A2 (en) | 2002-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023000411A (es) | Vacuna combinada de sars-cov-2 e influenza. | |
| FI931309A (fi) | Viralt bristfaelligt vaccin, som har producerats med en transkomplementerande cellinie | |
| CY1112749T1 (el) | Εμβολια διεγερσης/αναμνησης κατα της ελονοσιας | |
| BRPI0512421A (pt) | recombinantes de avipox expressando genes do vìrus da doença febre aftosa | |
| WO2008039408A3 (en) | Live bacterial vaccines for viral infection prophylaxis or treatment | |
| ATE447967T1 (de) | Verpackung von immunstimulierendem cpg in virusähnlichen partikeln: herstellungsverfahren und verwendung | |
| DK1335987T3 (da) | Modificeret vacciniavirus Ankara variant | |
| DE50206472D1 (de) | Attenuierte lebendimpfstoffe | |
| BRPI0816134A2 (pt) | Herpesvírus, sequência de dna, vetor, célula, vírus, método para produção de partículas infecciosas, partículas infecciosas, vacina, uso de herpesvírus ou da sequência de dna ou do vetor ou das partículas infecciosas, e, método para o tratamento preventivo e/ou terapêutico de uma doença. | |
| WO2000061737A3 (en) | Production of attenuated negative stranded RNA virus vaccines | |
| AR094725A1 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
| ZA201707985B (en) | Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine | |
| EP2552490A4 (en) | INFLUENZA MATRIX 2 PROTEIN ECKTOMOMAS, EXPRESSION SYSTEM THEREFOR AND USES THEREOF | |
| MX2020012913A (es) | Proteinas de consenso para el virus de la enfermedad de la fiebre aftosa (fmdv), secuencias de codificacion para estas y vacunas elaboradas a partir de estas. | |
| WO2016116905A9 (en) | Cmv antigens and uses thereof | |
| DK1425404T3 (da) | Vaccinia-MVA-E3L-mutanter og anvendelse deraf | |
| MY162027A (en) | Use of a poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents | |
| PT1370668E (pt) | Vacinas de vector baseadas em leporipox | |
| TW200734463A (en) | Marked bovine viral diarrhea virus vaccines | |
| PH12018502460A1 (en) | Arthrogenic alphavirus vaccine | |
| WO2004009763A3 (en) | Use of vaccinia virus deleted for the e3l gene as a vaccine vector | |
| WO2003080112A3 (en) | Imidazoquinolineamines as adjuvants in hiv dna vaccination | |
| WO2006113927A3 (en) | Immunogenic vaccinia peptides and methods of using same | |
| ATE303821T1 (de) | Neue vakzinformulierung aus dna-vakzine- inaktiviertem virus | |
| CA2366056A1 (en) | Non-spreading pestivirus |